Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 01, 2023

SELL
$0.43 - $0.77 $4,360 - $7,808
-10,141 Reduced 6.53%
145,050 $68,000
Q1 2023

May 05, 2023

BUY
$0.62 - $1.1 $33,666 - $59,730
54,300 Added 53.82%
155,191 $105,000
Q4 2022

Jan 24, 2023

BUY
$0.84 - $100.75 $20,160 - $2.42 Million
24,000 Added 31.21%
100,891 $0
Q3 2022

Nov 10, 2022

BUY
$4.61 - $116.0 $1,383 - $34,800
300 Added 0.39%
76,891 $312,000
Q2 2022

Aug 11, 2022

BUY
$3.99 - $7.22 $1,995 - $3,610
500 Added 0.66%
76,591 $433,000
Q1 2022

Apr 20, 2022

SELL
$5.28 - $9.17 $2,159 - $3,750
-409 Reduced 0.53%
76,091 $480,000
Q4 2021

Feb 02, 2022

BUY
$6.86 - $9.65 $4,116 - $5,790
600 Added 0.79%
76,500 $679,000
Q3 2021

Oct 28, 2021

BUY
$7.21 - $10.49 $28,479 - $41,435
3,950 Added 5.49%
75,900 $586,000
Q2 2021

Aug 13, 2021

BUY
$8.48 - $13.61 $34,344 - $55,120
4,050 Added 5.96%
71,950 $691,000
Q1 2021

May 06, 2021

SELL
$12.96 - $19.75 $246,240 - $375,250
-19,000 Reduced 21.86%
67,900 $921,000
Q4 2020

Feb 09, 2021

SELL
$12.74 - $18.49 $2,548 - $3,697
-200 Reduced 0.23%
86,900 $1.24 Million
Q3 2020

Nov 03, 2020

SELL
$5.86 - $18.47 $41,313 - $130,213
-7,050 Reduced 7.49%
87,100 $1.61 Million
Q2 2020

Jul 31, 2020

BUY
$3.79 - $6.08 $17,434 - $27,968
4,600 Added 5.14%
94,150 $542,000
Q1 2020

May 01, 2020

BUY
$3.51 - $5.36 $277,465 - $423,708
79,050 Added 752.86%
89,550 $344,000
Q4 2019

Feb 03, 2020

BUY
$4.71 - $5.4 $49,455 - $56,700
10,500 New
10,500 $56,000

Others Institutions Holding TFFP

# of Institutions
1
Shares Held
1M
Call Options Held
0
Put Options Held
0

About TFF Pharmaceuticals, Inc.


  • Ticker TFFP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,477,800
  • Market Cap $1.53M
  • Description
  • TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and condit...
More about TFFP
Track This Portfolio

Track Sigma Planning Corp Portfolio

Follow Sigma Planning Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

News

Stay updated on Sigma Planning Corp with notifications on news.